Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting

Identification of Predictive Factors for Survival of Patients With Recurrent Prostate Cancer From Clinical Features, Tissue Image Features and Molecular Biomarker Data

This study has been completed.
Sponsor:
Collaborators:
Aureon Biosciences, Inc.
NYU MEDICAL CENTER
Information provided by (Responsible Party):
Memorial Sloan Kettering Cancer Center
ClinicalTrials.gov Identifier:
NCT00578409
First received: December 19, 2007
Last updated: December 16, 2015
Last verified: December 2015
No Study Results Posted on ClinicalTrials.gov for this Study
  Study Status: This study has been completed.
  Study Completion Date: April 2010
  Primary Completion Date: April 2010 (Final data collection date for primary outcome measure)